State Street Corporation and SSGA Funds Management, Inc. filed a Schedule 13G with the SEC on November 10, 2026, disclosing their beneficial ownership of common stock in Hycroft Mining Holding Corp as of September 30, 2026.
State Street Corporation filed a Schedule 13G with the SEC on November 9, 2026, disclosing beneficial ownership of 937,952 shares of common stock in Idaho Strategic Resources Inc, representing 5.9% of the class, based on a triggering event dated September 30, 2026.
Yinan Ren filed Amendment No. 2 to a Schedule 13D with the SEC on November 10, 2026, disclosing an open-market purchase of 150,000 Class A Ordinary Shares of YYForce Inc. on November 9, 2026, and reporting aggregate beneficial ownership of 3,937,379 shares.
Westrock Coffee Company filed a Form S-3 registration statement with the SEC on November 10, 2026, registering up to $500,000,000 in securities on a delayed or continuous basis as a replacement for its prior shelf registration statement.
AST SpaceMobile, Inc. filed a Form 8-K on November 10, 2026, disclosing a press release issued November 9, 2026, announcing that Rakuten and AST SpaceMobile have established a joint venture called "Rakuten AST" to build a direct-to-device satellite communications network in Japan.
Alliance Entertainment Holding Corporation filed a Form 8-K on November 10, 2026, reporting the voting results from its 2026 Annual Meeting of Stockholders held on November 5, 2026.
NET Power Inc. filed an 8-K on November 10, 2026, disclosing that its Board of Directors approved an amendment to the stock option held by President and Chief Operating Officer Marc Horstman, changing post-termination exercise rights effective November 4, 2026.
Aptera Motors Corp. filed a Form 8-K on November 10, 2026, disclosing the suspension and termination of its at-the-market offering prospectus and providing preliminary cash figures for the quarter ended September 30, 2026.
PepGen Inc. filed a current report on November 10, 2026, disclosing third quarter 2026 financial results and announcing positive Phase 2 FREEDOM2-DM1 data from its 10mg/kg multiple ascending dose cohort.
PDS Biotechnology Corporation filed a Form 8-K on November 10, 2026, disclosing that NantWorks exercised outstanding common stock warrants to purchase an aggregate of 17,699,115 shares of common stock at an exercise price of $0.22 per share, generating approximately $3.9 million in gross proceeds …